A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Refractory or Relapsed Lymphoid Malignancies
Clinical trial NCT02175433 · COMPLETED
Trial details
- NCT number
- NCT02175433
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-14
- Primary completion
- 2019-10-29
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.